4//SEC Filing
MCKENZIE DIANA 4
Accession 0000875320-25-000182
CIK 0000875320other
Filed
May 4, 8:00 PM ET
Accepted
May 5, 4:52 PM ET
Size
9.4 KB
Accession
0000875320-25-000182
Insider Transaction Report
Form 4
MCKENZIE DIANA
Director
Transactions
- Award
Common Stock
2025-05-01+796→ 3,232 total - Award
Deferred Stock Units
2025-05-01+1,001→ 6,991.483 total→ Common Stock (1,001 underlying) - Disposition to Issuer
Common Stock
2025-05-01−1,001→ 2,231 total
Holdings
- 207(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.
- [F2]Upon the vesting of restricted stock units granted to Ms. McKenzie on May 1, 2024, Ms. McKenzie deferred the receipt of 1,001 shares of common stock and received instead 1,001 deferred stock units pursuant to our deferred compensation plan. As a result, Ms. McKenzie is reporting the disposition of 1,001 shares of common stock in exchange for an equal number of deferred stock units.
- [F3]Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death.
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeother
Related Parties
1- filerCIK 0001754648
Filing Metadata
- Form type
- 4
- Filed
- May 4, 8:00 PM ET
- Accepted
- May 5, 4:52 PM ET
- Size
- 9.4 KB